AD

Ankur Dullar

Active Director Director DIN 10434156
DIN 10434156 First appointment Dec 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Ankur Dullar

Data last updated:

Ankur Dullar is a Director at Analeptic Medic Private Limited (since 2023). The company operates in Pharma. Analeptic Medic Private Limited reported revenue of ₹95,631 (FY 2024).

DIN 10434156
Primary Designation Director
Industry Pharma
First Appointment 21 Dec 2023
Oldest Company Age 2 yrs
Largest company Analeptic Medic Private Limited · ₹95,631 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Analeptic Medic Private Limited U47721PB2023PTC060273
Director21 Dec 20232023₹95,631 (FY 2024)Active

Board colleagues of Ankur Dullar

NameDINCompanyDesignation
Parveen Dullar10434155Analeptic Medic Private LimitedDirector

Directorship timeline

Open interactive timeline →
Analeptic Medic Private Limited
Premium access

Shareholding and investment profile for Ankur Dullar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankur Dullar

Ankur Dullar currently holds 1 directorship: Analeptic Medic Private Limited (Director, since 21 Dec 2023, revenue ₹95,631 (FY 2024)).

Ankur Dullar was first appointed on 21 Dec 2023 as Director at Analeptic Medic Private Limited.

The current boards of Ankur Dullar's companies include Parveen Dullar (Analeptic Medic Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available